Growing community of inventors

Flemington, NJ, United States of America

Dora Visky

Average Co-Inventor Count = 6.77

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Dora ViskyThomas Lee (2 patents)Dora ViskyAnil Menon (2 patents)Dora ViskyDarshan Parikh (2 patents)Dora ViskyMing J Chen (2 patents)Dora ViskyNathan Andrew Boersen (2 patents)Dora ViskyAnjali Agrawal (2 patents)Dora ViskyPrajwal Gunwanth Thool (2 patents)Dora ViskyXiaozhang Liang (2 patents)Dora ViskyRuimin Xie (2 patents)Dora ViskyShyam Babu Karki (2 patents)Dora ViskyBenjamin Cohen (1 patent)Dora ViskyJean Xu (1 patent)Dora ViskyYing Li (1 patent)Dora ViskyMatthew Michael Kreilein (1 patent)Dora ViskyWilliam Wei-Hwa Leong (1 patent)Dora ViskyYing Li (1 patent)Dora ViskyDarshan K Parikh (1 patent)Dora ViskyDarshan K Parikh (0 patent)Dora ViskyThomas Lee (0 patent)Dora ViskyDora Visky (4 patents)Thomas LeeThomas Lee (33 patents)Anil MenonAnil Menon (14 patents)Darshan ParikhDarshan Parikh (13 patents)Ming J ChenMing J Chen (8 patents)Nathan Andrew BoersenNathan Andrew Boersen (7 patents)Anjali AgrawalAnjali Agrawal (3 patents)Prajwal Gunwanth ThoolPrajwal Gunwanth Thool (3 patents)Xiaozhang LiangXiaozhang Liang (2 patents)Ruimin XieRuimin Xie (2 patents)Shyam Babu KarkiShyam Babu Karki (2 patents)Benjamin CohenBenjamin Cohen (197 patents)Jean XuJean Xu (49 patents)Ying LiYing Li (27 patents)Matthew Michael KreileinMatthew Michael Kreilein (18 patents)William Wei-Hwa LeongWilliam Wei-Hwa Leong (6 patents)Ying LiYing Li (65 patents)Darshan K ParikhDarshan K Parikh (2 patents)Darshan K ParikhDarshan K Parikh (0 patent)Thomas LeeThomas Lee (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Celgene Corporation (2 from 550 patents)

2. Signal Pharmaceuticals, Inc. (2 from 169 patents)


4 patents:

1. 12064427 - Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same

2. 11779580 - Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the

3. 10052322 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

4. 9359364 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…